(1)
EFFICIENCY OF THE VINORELBINE – CAPECITABINE + BEVASIZUMAB REGIMEN IN THE TREATMENT OF PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER. Web med. 2024, 2 (11), 91-97.